Progress Scientific Inc.
$72,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada
The Firm is developing a pharmacological therapy using drugs that target the alpha2beta2 subtype of nicotonic acetylcholine receptor to counter respiratory depression associated with opiates (e.g. fen...